MeSH tree: C06.552.241.519
Beneficial gut microbes and the body work together to fine-tune fat metabolism and cholesterol levels, according to a new preclinical study by investigators from Weill Cornell Medicine and the Boyce Thompson Institute at ...
Jan 9, 2025
0
67
Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with an increased CAD risk, according to a review published online Nov. 21 in the Journal of Clinical ...
Dec 22, 2024
0
20
A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental study, pharmacological inhibition of an enzyme that plays a central role in fat metabolism promoted ...
Dec 18, 2024
0
11
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), impacts roughly 30% of the global adult population. The disease spans from benign fat accumulation ...
Dec 9, 2024
0
55
Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered a key biological reason why obesity increases the risk of type 2 diabetes, and it boils down to size—specifically ...
Nov 22, 2024
0
49
Scientists at deCODE genetics have published a study in Nature Communications that sheds light on how body mass index (BMI) influences the risk of various diseases that are comorbid with obesity. The study, which used genetic ...
Nov 12, 2024
0
29
A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for cardiovascular disease—the leading cause of death worldwide.
Oct 18, 2024
0
153
People with obesity who are long-time exercisers have healthier belly fat tissue and can store fat there more effectively than nonexercisers with obesity, according to a new study from a team of researchers at the University ...
Sep 10, 2024
0
70
Research from the lab of Jason Kim, Ph.D., professor of molecular medicine and medicine, identified a novel pathway in the progression of metabolic liver disease that could be targeted for potential therapies.
Aug 30, 2024
0
51
A research team from Université Laval has shown the benefits of camu-camu on non-alcoholic fatty liver disease, which affects over seven million people in Canada. This exotic fruit reduces liver fat levels.
Aug 21, 2024
0
99
